Peptide questions · VK2735
VK2735 half-life: how long it stays in your system
Reviewed Evidence: ModeratePublished by PepVault
VK2735’s half-life is about 9 days (216 hours), a figure measured in people.
Half of a dose of VK2735 is gone after about 9 days, and about 97% after 45 days, five half-lives.
How much VK2735 is left after each half-life
Each half-life halves whatever is left. Starting from one dose of VK2735, about 50% remains after 9 days, 25% after 18 days and 12.5% after 27 days.
| Half-lives | Time after a dose | Left | Cleared |
|---|---|---|---|
| 1 | about 9 days | 50% | 50% |
| 2 | about 18 days | 25% | 75% |
| 3 | about 27 days | 12.5% | 87.5% |
| 4 | about 36 days | 6.3% | 93.8% |
| 5 | about 45 days | 3.1% | 96.9% |
| 7 | about 63 days | 0.8% | 99.2% |
What is left of one dose, half-life by half-life: an estimate from the stated figure.
By about 45 days (five half-lives) 96.9% of a single dose of VK2735 has cleared, and by about 63 days (seven) 99.2%. A day after a dose about 92.6% of it is still there.
This is elimination arithmetic: it describes how the level in the blood falls after a dose, not how long a drug test can find it, and this page makes no claim about detection.
The arithmetic assumes the body clears the compound at a steady rate, the simple one-compartment model the half-life calculator uses; absorption from under the skin, the route and the person all move the real curve.

Model. Individual results vary.
VK2735 on a regular schedule
The library lists VK2735’s frequency as “Weekly”, a dose every 7 days, which is 0.8 of its half-lives.
When the next dose of VK2735 comes, about 58.3% of the one before is still there, so the doses overlap and the level climbs over the first ones. It stops climbing after 4 to 5 half-lives, about 36–45 days, which on this schedule is about 6–7 doses. From then on each peak of VK2735 sits about 2.4 times as high as a single dose’s.
An estimate on the library’s typical schedule from the half-life above, not a measurement.
VK2735 against other metabolic & GLP-1 compounds
The library states a half-life with a number for 20 of its metabolic & GLP-1 compounds. VK2735’s is the seventeenth shortest of the 20: the shortest is oxytocin at about 1–6 minutes, the longest eloralintide at about 14 days (336 hours).
| Compound | Half-life | Kind of figure |
|---|---|---|
| Oxytocin | about 1–6 minutes | source not given |
| Pramlintide | about 48 minutes | drug label |
| Exenatide | about 2.4 hours | drug label |
| Setmelanotide | about 11 hours | drug label |
| Liraglutide | about 13 hours | source not given |
| Orforglipron | about 1.2–2 days (29–49 hours) | drug label |
| Amycretin | about 3.7 days (88 hours) | measured in people |
| Dulaglutide | about 5 days (120 hours) | drug label |
| Tirzepatide | about 5 days (120 hours) | drug label |
| Ecnoglutide | about 5.5 days (132 hours) | measured in people |
| Enicepatide | about 5.5 days (132 hours) | measured in people |
| Retatrutide | about 6 days (144 hours) | measured in people |
| Cagrilintide | about 7 days (168 hours) | measured in people |
| CagriSema | about 7 days (168 hours) | measured in people |
| Semaglutide | about 7 days (168 hours) | drug label |
| Semaglutide (oral) | about 7 days (168 hours) | source not given |
| VK2735 | about 9 days (216 hours) | measured in people |
| Mazdutide | about 10 days (240 hours) | drug label |
| Petrelintide | about 10 days (240 hours) | measured in people |
| Eloralintide | about 14 days (336 hours) | measured in people |
What the half-life explains about how often VK2735 is dosed
Spacing doses of VK2735 0.8 half-lives apart means more than half of each dose is still there at the next one, which is why VK2735 builds up over its first weeks and then holds a fairly even level.
The library’s timing note
Once weekly SubQ, same day each week, in its trials. VENTURE started at 2.5 mg (5 mg for its 15 mg group) and stepped up every 3 weeks to 5, 10 or 15 mg; phase 3 tests 7.5, 12.5 and 17.5 mg. The tablet is a daily dose in its own trials (27.5 to 55 mg in phase 3), not interchangeable mg for mg with the shot. These are trial schedules, not an approved regimen.
Where the VK2735 figure comes from
As the library states it
~9 days (measured in people: 170–250 hours after single doses, Viking phase 1, 2023)
VK2735’s half-life was measured in people, the firmest kind of figure after a drug label, though one small study’s number can still move as more are run.
Questions people ask
What is the half-life of VK2735?
VK2735’s half-life is about 9 days (216 hours), a figure measured in people. Half of a dose of VK2735 is gone after about 9 days, and about 97% after 45 days, five half-lives.
How long does VK2735 stay in your system?
By elimination arithmetic, about 96.9% of a single dose of VK2735 has cleared after five half-lives, about 45 days, and 99.2% after seven, about 63 days. That is how its level in the blood falls, not a drug-test detection window.
How long does VK2735 take to reach steady state?
On the library’s schedule (Weekly), VK2735’s level stops climbing after 4 to 5 half-lives, about 36–45 days, or 6–7 doses.
Is the half-life of VK2735 measured in people?
VK2735’s half-life was measured in people, the firmest kind of figure after a drug label, though one small study’s number can still move as more are run.